COVID patients treated with hepatitis drug FOUR times more likely to have cleared infection quickly
Coronavirus patients treated with a experimental hepatitis drug were FOUR times more likely to have cleared the infection within seven days, study finds Peginterferon-lambda is a man-made form of a naturally occurring protein that calls for immune cells to attack a virus and is mainly used to treat hepatitis Receptors for the drug are found … Read more
